02919nam 2200877z- 450 991056645910332120220506(CKB)5680000000037790(oapen)https://directory.doabooks.org/handle/20.500.12854/81067(oapen)doab81067(EXLCZ)99568000000003779020202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPharmacogenomicsFrom Basic Research to Clinical ImplementationBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (162 p.)3-0365-2835-0 3-0365-2834-2 This Special Issue focuses on the current state of pharmacogenomics (PGx) and the extensive translational process, including the identification of functionally important PGx variation; the characterization of PGx haplotypes and metabolizer statuses, their clinical interpretation, clinical decision support, and the incorporation of PGx into clinical care.Pharmacogenomics Medicine and NursingbicsscPharmacologybicsscadaptationartificial intelligencebest practice alerts (BPAs)chronic diseasechronic kidney diseaseclinical actionabilityclinical decision support (CDS)clinical translationcommunity pharmacyCYP3A5electronic health records (EHR)electronic medical recordgenetic counselinggenetic privacygenomic indicatorsgenotypehuman evolutionimplementationmachine learningmedication managementn/apediatricspersonalized medicinepharmaco-economicspharmacogenespharmacogeneticspharmacogenetics servicepharmacogenomicpharmacogenomic testingpharmacogenomicspharmacogenomics (PGx)phenotypepolymorphismpolymorphismspolypharmacypre-emptiveprecision medicineprogressionqualitativereturn of resultsscreeningUS Food and Drug AdministrationMedicine and NursingPharmacologyScheinfeldt Laura Bedt1299056Scheinfeldt Laura BothBOOK9910566459103321Pharmacogenomics3025009UNINA